Rank | Gene Set | Z-score |
---|---|---|
1 | oxygen transport (GO:0015671) | 9.36341736 |
2 | gas transport (GO:0015669) | 8.66551959 |
3 | porphyrin-containing compound biosynthetic process (GO:0006779) | 7.87388940 |
4 | heme biosynthetic process (GO:0006783) | 7.68678635 |
5 | tetrapyrrole biosynthetic process (GO:0033014) | 7.03268503 |
6 | ribosomal small subunit assembly (GO:0000028) | 6.51995694 |
7 | porphyrin-containing compound metabolic process (GO:0006778) | 6.12479135 |
8 | heme metabolic process (GO:0042168) | 5.92787725 |
9 | * erythrocyte maturation (GO:0043249) | 5.91998129 |
10 | erythrocyte development (GO:0048821) | 5.66713719 |
11 | viral transcription (GO:0019083) | 5.59216676 |
12 | * definitive hemopoiesis (GO:0060216) | 5.39374352 |
13 | translational termination (GO:0006415) | 5.38427689 |
14 | neutrophil activation involved in immune response (GO:0002283) | 4.92918050 |
15 | translational elongation (GO:0006414) | 4.66942396 |
16 | regulation of platelet aggregation (GO:0090330) | 4.50827802 |
17 | * erythrocyte differentiation (GO:0030218) | 4.48697231 |
18 | * embryonic hemopoiesis (GO:0035162) | 4.42711268 |
19 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.42610582 |
20 | * myeloid cell development (GO:0061515) | 4.37858000 |
21 | endothelium development (GO:0003158) | 4.35660831 |
22 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.35328375 |
23 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.32779313 |
24 | ribosomal small subunit biogenesis (GO:0042274) | 4.29618940 |
25 | hemoglobin metabolic process (GO:0020027) | 4.28244862 |
26 | protein targeting to ER (GO:0045047) | 4.24842634 |
27 | cotranslational protein targeting to membrane (GO:0006613) | 4.24128927 |
28 | DNA unwinding involved in DNA replication (GO:0006268) | 4.19858218 |
29 | iron ion import (GO:0097286) | 4.18654695 |
30 | cellular protein complex disassembly (GO:0043624) | 4.14418401 |
31 | maturation of SSU-rRNA (GO:0030490) | 4.11401666 |
32 | viral life cycle (GO:0019058) | 4.10956405 |
33 | * regulation of erythrocyte differentiation (GO:0045646) | 4.09060767 |
34 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.07442205 |
35 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 4.06334218 |
36 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.97417864 |
37 | protein localization to endoplasmic reticulum (GO:0070972) | 3.95751827 |
38 | * megakaryocyte development (GO:0035855) | 3.95075874 |
39 | translational initiation (GO:0006413) | 3.94832994 |
40 | tetrapyrrole metabolic process (GO:0033013) | 3.92712024 |
41 | protein complex disassembly (GO:0043241) | 3.80824762 |
42 | response to methylmercury (GO:0051597) | 3.80000833 |
43 | platelet dense granule organization (GO:0060155) | 3.70589532 |
44 | response to insecticide (GO:0017085) | 3.67904573 |
45 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.67477623 |
46 | DNA replication initiation (GO:0006270) | 3.59925209 |
47 | regulation of granulocyte differentiation (GO:0030852) | 3.56821474 |
48 | DNA strand elongation (GO:0022616) | 3.55384360 |
49 | * granulocyte differentiation (GO:0030851) | 3.54109532 |
50 | negative regulation of viral entry into host cell (GO:0046597) | 3.53112869 |
51 | regulation of platelet activation (GO:0010543) | 3.52726301 |
52 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.51133162 |
53 | macromolecular complex disassembly (GO:0032984) | 3.51103830 |
54 | pigment biosynthetic process (GO:0046148) | 3.49760418 |
55 | platelet aggregation (GO:0070527) | 3.38109632 |
56 | regulation of DNA endoreduplication (GO:0032875) | 3.34352669 |
57 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.31835342 |
58 | regulation of mast cell degranulation (GO:0043304) | 3.31447989 |
59 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.29385858 |
60 | IMP biosynthetic process (GO:0006188) | 3.29361478 |
61 | response to lead ion (GO:0010288) | 3.28780440 |
62 | * positive regulation of erythrocyte differentiation (GO:0045648) | 3.27418526 |
63 | innate immune response in mucosa (GO:0002227) | 3.27368424 |
64 | positive regulation of mast cell activation (GO:0033005) | 3.21412355 |
65 | purine-containing compound salvage (GO:0043101) | 3.18509977 |
66 | protein localization to chromosome, centromeric region (GO:0071459) | 3.17332195 |
67 | protein localization to kinetochore (GO:0034501) | 3.14702605 |
68 | mRNA catabolic process (GO:0006402) | 3.14250048 |
69 | neutrophil activation (GO:0042119) | 3.11851837 |
70 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.11304441 |
71 | positive regulation of B cell differentiation (GO:0045579) | 3.10878730 |
72 | secretory granule organization (GO:0033363) | 3.10219239 |
73 | regulation of response to osmotic stress (GO:0047484) | 3.10202537 |
74 | RNA catabolic process (GO:0006401) | 3.09889816 |
75 | regulation of megakaryocyte differentiation (GO:0045652) | 3.08992886 |
76 | negative regulation of RNA splicing (GO:0033119) | 3.08096862 |
77 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.06744041 |
78 | adenosine receptor signaling pathway (GO:0001973) | 3.04642290 |
79 | DNA topological change (GO:0006265) | 3.04548561 |
80 | positive regulation of vasculogenesis (GO:2001214) | 3.00180715 |
81 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.99636634 |
82 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.99098304 |
83 | histamine secretion (GO:0001821) | 2.97991531 |
84 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.97973407 |
85 | thrombin receptor signaling pathway (GO:0070493) | 2.95762902 |
86 | autophagic vacuole fusion (GO:0000046) | 2.94974125 |
87 | angiogenesis involved in wound healing (GO:0060055) | 2.94425457 |
88 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.94280334 |
89 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.93373542 |
90 | granulocyte activation (GO:0036230) | 2.93302529 |
91 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.91796401 |
92 | telomere maintenance via recombination (GO:0000722) | 2.91658433 |
93 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.91372114 |
94 | regulation of histone H3-K9 methylation (GO:0051570) | 2.90854003 |
95 | response to arsenic-containing substance (GO:0046685) | 2.89281402 |
96 | Peyers patch development (GO:0048541) | 2.89235591 |
97 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.89235591 |
98 | pigment metabolic process (GO:0042440) | 2.86341021 |
99 | regulation of mast cell activation (GO:0033003) | 2.85668552 |
100 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.85166681 |
101 | IMP metabolic process (GO:0046040) | 2.84568228 |
102 | protein targeting to membrane (GO:0006612) | 2.84204380 |
103 | antibacterial humoral response (GO:0019731) | 2.84017887 |
104 | leukocyte degranulation (GO:0043299) | 2.83280870 |
105 | nerve growth factor signaling pathway (GO:0038180) | 2.82584176 |
106 | cellular response to arsenic-containing substance (GO:0071243) | 2.81430411 |
107 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.79194640 |
108 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.78424033 |
109 | hepatocyte apoptotic process (GO:0097284) | 2.78345780 |
110 | organelle membrane fusion (GO:0090174) | 2.77711765 |
111 | response to peptidoglycan (GO:0032494) | 2.77166001 |
112 | blood vessel maturation (GO:0001955) | 2.76552753 |
113 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.76245394 |
114 | response to thyroid hormone (GO:0097066) | 2.75886453 |
115 | mitotic recombination (GO:0006312) | 2.75489080 |
116 | regulation of RNA export from nucleus (GO:0046831) | 2.75252783 |
117 | sister chromatid segregation (GO:0000819) | 2.74454260 |
118 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.72436741 |
119 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.71939112 |
120 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.71256618 |
121 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.71048682 |
122 | negative regulation of histone methylation (GO:0031061) | 2.70992005 |
123 | glycine transport (GO:0015816) | 2.70703693 |
124 | regulation of hypersensitivity (GO:0002883) | 2.70492211 |
125 | ribosomal large subunit biogenesis (GO:0042273) | 2.68953844 |
126 | mitotic sister chromatid segregation (GO:0000070) | 2.68793334 |
127 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.68500428 |
128 | chromatin assembly (GO:0031497) | 2.68248037 |
129 | positive regulation of granulocyte differentiation (GO:0030854) | 2.66981418 |
130 | kinetochore organization (GO:0051383) | 2.66931270 |
131 | one-carbon compound transport (GO:0019755) | 2.65886679 |
132 | negative regulation of norepinephrine secretion (GO:0010700) | 2.64853531 |
133 | regulation of histone H3-K4 methylation (GO:0051569) | 2.64203726 |
134 | N-terminal protein amino acid acetylation (GO:0006474) | 2.63778587 |
135 | T cell homeostasis (GO:0043029) | 2.62593911 |
136 | DNA replication checkpoint (GO:0000076) | 2.62244948 |
137 | translesion synthesis (GO:0019985) | 2.61924155 |
138 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.61507657 |
139 | * platelet formation (GO:0030220) | 2.59659964 |
140 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.59600891 |
141 | * hemopoiesis (GO:0030097) | 2.59453103 |
142 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.57151369 |
143 | chromatin assembly or disassembly (GO:0006333) | 2.53787695 |
144 | mucosal immune response (GO:0002385) | 2.53280424 |
145 | antimicrobial humoral response (GO:0019730) | 2.51397751 |
146 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.50669856 |
147 | positive regulation of mast cell degranulation (GO:0043306) | 2.50669856 |
148 | negative regulation of focal adhesion assembly (GO:0051895) | 2.50227506 |
149 | negative regulation of cell junction assembly (GO:1901889) | 2.50227506 |
150 | negative regulation of adherens junction organization (GO:1903392) | 2.50227506 |
151 | ether lipid metabolic process (GO:0046485) | 2.49029480 |
152 | telomere maintenance via telomere lengthening (GO:0010833) | 2.48300290 |
153 | positive regulation of bone resorption (GO:0045780) | 2.47822305 |
154 | positive regulation of bone remodeling (GO:0046852) | 2.47822305 |
155 | regulation of B cell differentiation (GO:0045577) | 2.47557333 |
156 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.46857017 |
157 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.46284088 |
158 | regulation of integrin activation (GO:0033623) | 2.45074322 |
159 | modulation by virus of host process (GO:0019054) | 2.44359619 |
160 | protoporphyrinogen IX metabolic process (GO:0046501) | 11.1653725 |
161 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 10.2933973 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.99216214 |
2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 5.06394440 |
3 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 4.60945672 |
4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.90024092 |
5 | GATA1_22025678_ChIP-Seq_K562_Human | 3.84441446 |
6 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.19313931 |
7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.16355237 |
8 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 3.10103621 |
9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.82279383 |
10 | * GATA1_19941826_ChIP-Seq_K562_Human | 2.73533531 |
11 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.70634868 |
12 | MYC_22102868_ChIP-Seq_BL_Human | 2.61393843 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.57590187 |
14 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.54733877 |
15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.49735736 |
16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.48419152 |
17 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.41237590 |
18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.31936655 |
19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.24978246 |
20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.22572587 |
21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.05995640 |
22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03536278 |
23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.96835249 |
24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.93318541 |
25 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.93276939 |
26 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.85591839 |
27 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.81538869 |
28 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.77655032 |
29 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.76195049 |
30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.75427633 |
31 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.71627810 |
32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.71238511 |
33 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.66978707 |
34 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65289164 |
35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.65032464 |
36 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63354819 |
37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.60860632 |
38 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60437522 |
39 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.59676731 |
40 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.58840095 |
41 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.58676726 |
42 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.58591712 |
43 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.58505763 |
44 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.58468420 |
45 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.55021529 |
46 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.54844564 |
47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54181301 |
48 | MAF_26560356_Chip-Seq_TH1_Human | 1.52561507 |
49 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.50552891 |
50 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.49831464 |
51 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.48035376 |
52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.45203480 |
53 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.44136330 |
54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43859947 |
55 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.42011493 |
56 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.41153974 |
57 | UTX_26944678_Chip-Seq_JUKART_Human | 1.41013491 |
58 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.40433300 |
59 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40005023 |
60 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.37367508 |
61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34747758 |
62 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.32306677 |
63 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.32001807 |
64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.31700735 |
65 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.31460062 |
66 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.31017107 |
67 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30390644 |
68 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29278804 |
69 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.28756897 |
70 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.27536839 |
71 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26528853 |
72 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.26213270 |
73 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.24898100 |
74 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.23272462 |
75 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23122098 |
76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22772120 |
77 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21458177 |
78 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.20529370 |
79 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.19664685 |
80 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.18959151 |
81 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.18317640 |
82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17515690 |
83 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14987134 |
84 | MYB_26560356_Chip-Seq_TH2_Human | 1.13974556 |
85 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.11326714 |
86 | MYB_26560356_Chip-Seq_TH1_Human | 1.11019071 |
87 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10884776 |
88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09761180 |
89 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09757406 |
90 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.09735120 |
91 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.09681941 |
92 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.09414985 |
93 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.09359400 |
94 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.09226258 |
95 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.08828004 |
96 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.08692572 |
97 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08633859 |
98 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.07392701 |
99 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.06036986 |
100 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05979232 |
101 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.05950816 |
102 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05869676 |
103 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.05433575 |
104 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.04284087 |
105 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.03168008 |
106 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.02334852 |
107 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.02159116 |
108 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.01989281 |
109 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01651958 |
110 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00979986 |
111 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.00742102 |
112 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.99646408 |
113 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.99355538 |
114 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98907624 |
115 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98901926 |
116 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.98842270 |
117 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.97865610 |
118 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97113938 |
119 | MAF_26560356_Chip-Seq_TH2_Human | 0.96347961 |
120 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.95998449 |
121 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95375932 |
122 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94621707 |
123 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86021651 |
124 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80893231 |
125 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.80717301 |
126 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.80590404 |
127 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.79773755 |
128 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.79264275 |
129 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.75290837 |
130 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.73814844 |
131 | GATA3_26560356_Chip-Seq_TH2_Human | 0.73570862 |
132 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.73436432 |
133 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.66847353 |
134 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.66471487 |
135 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.65842273 |
136 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.65809305 |
137 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.64066933 |
138 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.63970474 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004147_increased_porphyrin_level | 7.82557143 |
2 | MP0003656_abnormal_erythrocyte_physiolo | 7.41758553 |
3 | MP0005397_hematopoietic_system_phenotyp | 3.43711655 |
4 | MP0001545_abnormal_hematopoietic_system | 3.43711655 |
5 | MP0002396_abnormal_hematopoietic_system | 3.34788369 |
6 | MP0004808_abnormal_hematopoietic_stem | 3.13250881 |
7 | MP0003111_abnormal_nucleus_morphology | 2.93116816 |
8 | MP0010094_abnormal_chromosome_stability | 2.73247815 |
9 | MP0005464_abnormal_platelet_physiology | 2.56638818 |
10 | MP0005083_abnormal_biliary_tract | 2.43917534 |
11 | MP0000465_gastrointestinal_hemorrhage | 2.31256844 |
12 | MP0009278_abnormal_bone_marrow | 2.30462696 |
13 | MP0003077_abnormal_cell_cycle | 2.20351975 |
14 | MP0002877_abnormal_melanocyte_morpholog | 2.12917834 |
15 | * MP0002398_abnormal_bone_marrow | 2.09277422 |
16 | MP0006054_spinal_hemorrhage | 2.08099328 |
17 | MP0000490_abnormal_crypts_of | 1.98318982 |
18 | MP0003693_abnormal_embryo_hatching | 1.95504242 |
19 | MP0008004_abnormal_stomach_pH | 1.90368218 |
20 | MP0009697_abnormal_copulation | 1.89297413 |
21 | MP0005174_abnormal_tail_pigmentation | 1.88827579 |
22 | * MP0002722_abnormal_immune_system | 1.82287546 |
23 | * MP0000689_abnormal_spleen_morphology | 1.76399565 |
24 | MP0010307_abnormal_tumor_latency | 1.66686773 |
25 | * MP0002429_abnormal_blood_cell | 1.58996641 |
26 | MP0008057_abnormal_DNA_replication | 1.58940589 |
27 | MP0008058_abnormal_DNA_repair | 1.57105838 |
28 | MP0000685_abnormal_immune_system | 1.54905580 |
29 | MP0004957_abnormal_blastocyst_morpholog | 1.54001835 |
30 | MP0003943_abnormal_hepatobiliary_system | 1.52807875 |
31 | MP0005671_abnormal_response_to | 1.52550024 |
32 | MP0003567_abnormal_fetal_cardiomyocyte | 1.51746249 |
33 | MP0009333_abnormal_splenocyte_physiolog | 1.42647798 |
34 | MP0002095_abnormal_skin_pigmentation | 1.39944498 |
35 | MP0003172_abnormal_lysosome_physiology | 1.39702251 |
36 | MP0000703_abnormal_thymus_morphology | 1.36546103 |
37 | MP0008007_abnormal_cellular_replicative | 1.35188337 |
38 | MP0000716_abnormal_immune_system | 1.27866033 |
39 | MP0010368_abnormal_lymphatic_system | 1.23426064 |
40 | MP0005025_abnormal_response_to | 1.22173142 |
41 | * MP0000313_abnormal_cell_death | 1.21006022 |
42 | MP0005075_abnormal_melanosome_morpholog | 1.19026214 |
43 | MP0002132_abnormal_respiratory_system | 1.18457001 |
44 | MP0002019_abnormal_tumor_incidence | 1.18402303 |
45 | MP0003300_gastrointestinal_ulcer | 1.16184553 |
46 | MP0002420_abnormal_adaptive_immunity | 1.15017220 |
47 | MP0001819_abnormal_immune_cell | 1.13773288 |
48 | MP0000350_abnormal_cell_proliferation | 1.12190535 |
49 | MP0005636_abnormal_mineral_homeostasis | 1.11771281 |
50 | MP0001835_abnormal_antigen_presentation | 1.10609286 |
51 | MP0004084_abnormal_cardiac_muscle | 1.09157821 |
52 | MP0002452_abnormal_antigen_presenting | 1.04405413 |
53 | MP0002405_respiratory_system_inflammati | 1.03847548 |
54 | MP0001800_abnormal_humoral_immune | 1.03297847 |
55 | MP0009379_abnormal_foot_pigmentation | 1.01870325 |
56 | MP0008260_abnormal_autophagy | 1.01228092 |
57 | MP0004130_abnormal_muscle_cell | 0.99500973 |
58 | MP0001879_abnormal_lymphatic_vessel | 0.98635409 |
59 | MP0005084_abnormal_gallbladder_morpholo | 0.97218331 |
60 | MP0001853_heart_inflammation | 0.96999465 |
61 | MP0003436_decreased_susceptibility_to | 0.96764482 |
62 | * MP0002086_abnormal_extraembryonic_tissu | 0.96064522 |
63 | MP0002723_abnormal_immune_serum | 0.94819890 |
64 | MP0003724_increased_susceptibility_to | 0.94184711 |
65 | MP0010030_abnormal_orbit_morphology | 0.91835612 |
66 | MP0002419_abnormal_innate_immunity | 0.91504464 |
67 | MP0000598_abnormal_liver_morphology | 0.90562306 |
68 | * MP0008770_decreased_survivor_rate | 0.88080894 |
69 | MP0008775_abnormal_heart_ventricle | 0.87894263 |
70 | * MP0002080_prenatal_lethality | 0.87060772 |
71 | MP0001915_intracranial_hemorrhage | 0.86653701 |
72 | MP0010155_abnormal_intestine_physiology | 0.86074236 |
73 | MP0005000_abnormal_immune_tolerance | 0.85851714 |
74 | MP0006036_abnormal_mitochondrial_physio | 0.84030273 |
75 | MP0003303_peritoneal_inflammation | 0.83985377 |
76 | MP0003191_abnormal_cellular_cholesterol | 0.83850936 |
77 | MP0003866_abnormal_defecation | 0.82641163 |
78 | MP0001873_stomach_inflammation | 0.82587935 |
79 | MP0002148_abnormal_hypersensitivity_rea | 0.81910940 |
80 | MP0003186_abnormal_redox_activity | 0.81744700 |
81 | MP0002166_altered_tumor_susceptibility | 0.81394247 |
82 | MP0005451_abnormal_body_composition | 0.79315017 |
83 | MP0009785_altered_susceptibility_to | 0.79096646 |
84 | * MP0001697_abnormal_embryo_size | 0.78722729 |
85 | * MP0009931_abnormal_skin_appearance | 0.78242034 |
86 | * MP0001730_embryonic_growth_arrest | 0.77064215 |
87 | MP0000609_abnormal_liver_physiology | 0.76735741 |
88 | MP0001851_eye_inflammation | 0.75791772 |
89 | MP0003763_abnormal_thymus_physiology | 0.75130213 |
90 | MP0004036_abnormal_muscle_relaxation | 0.74943402 |
91 | MP0010352_gastrointestinal_tract_polyps | 0.73847932 |
92 | MP0004947_skin_inflammation | 0.73827839 |
93 | MP0000372_irregular_coat_pigmentation | 0.73801321 |
94 | MP0004197_abnormal_fetal_growth/weight/ | 0.72463437 |
95 | MP0009765_abnormal_xenobiotic_induced | 0.72273417 |
96 | MP0002009_preneoplasia | 0.71501229 |
97 | MP0000343_altered_response_to | 0.71443588 |
98 | MP0001790_abnormal_immune_system | 0.71185138 |
99 | MP0005387_immune_system_phenotype | 0.71185138 |
100 | * MP0003984_embryonic_growth_retardation | 0.70306400 |
101 | MP0003828_pulmonary_edema | 0.70153783 |
102 | MP0002928_abnormal_bile_duct | 0.69504081 |
103 | MP0005167_abnormal_blood-brain_barrier | 0.69086669 |
104 | MP0001663_abnormal_digestive_system | 0.68328833 |
105 | MP0000230_abnormal_systemic_arterial | 0.68120705 |
106 | MP0009763_increased_sensitivity_to | 0.67890150 |
107 | * MP0002088_abnormal_embryonic_growth/wei | 0.67718716 |
108 | MP0000858_altered_metastatic_potential | 0.66674708 |
109 | MP0002138_abnormal_hepatobiliary_system | 0.65712694 |
110 | MP0000015_abnormal_ear_pigmentation | 0.64901135 |
111 | * MP0005380_embryogenesis_phenotype | 0.64355638 |
112 | * MP0001672_abnormal_embryogenesis/_devel | 0.64355638 |
113 | MP0006035_abnormal_mitochondrial_morpho | 0.63348288 |
114 | MP0003045_fibrosis | 0.63004774 |
115 | MP0000249_abnormal_blood_vessel | 0.62499431 |
116 | MP0008872_abnormal_physiological_respon | 0.62474194 |
117 | MP0003786_premature_aging | 0.62473674 |
118 | MP0005171_absent_coat_pigmentation | 0.62003442 |
119 | MP0009764_decreased_sensitivity_to | 0.61789078 |
120 | MP0006276_abnormal_autonomic_nervous | 0.61243667 |
121 | MP0008995_early_reproductive_senescence | 0.61238298 |
122 | MP0000477_abnormal_intestine_morphology | 0.61226112 |
123 | MP0005058_abnormal_lysosome_morphology | 0.61218639 |
124 | MP0008469_abnormal_protein_level | 0.60834876 |
125 | MP0001845_abnormal_inflammatory_respons | 0.60332269 |
126 | MP0003718_maternal_effect | 0.59047655 |
127 | MP0003566_abnormal_cell_adhesion | 0.58002015 |
128 | MP0005535_abnormal_body_temperature | 0.57786942 |
129 | MP0005647_abnormal_sex_gland | 0.56269865 |
130 | MP0004484_altered_response_of | 0.55478779 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Poikilocytosis (HP:0004447) | 9.72096628 |
2 | Acanthocytosis (HP:0001927) | 7.04286934 |
3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.29470581 |
4 | Abnormal number of erythroid precursors (HP:0012131) | 6.23361382 |
5 | Petechiae (HP:0000967) | 6.07676668 |
6 | Reticulocytosis (HP:0001923) | 6.03113319 |
7 | Hypochromic microcytic anemia (HP:0004840) | 5.72670237 |
8 | Prolonged bleeding time (HP:0003010) | 5.54449401 |
9 | Abnormal hemoglobin (HP:0011902) | 5.37241302 |
10 | Abnormality of reticulocytes (HP:0004312) | 5.25086449 |
11 | Impaired platelet aggregation (HP:0003540) | 4.18925444 |
12 | Abnormal platelet function (HP:0011869) | 4.18925444 |
13 | Hypochromic anemia (HP:0001931) | 3.94571417 |
14 | Cholelithiasis (HP:0001081) | 3.91579533 |
15 | Reticulocytopenia (HP:0001896) | 3.86372014 |
16 | Microcytic anemia (HP:0001935) | 3.85386274 |
17 | Hyperbilirubinemia (HP:0002904) | 3.82721502 |
18 | Pallor (HP:0000980) | 3.81386390 |
19 | Diaphragmatic weakness (HP:0009113) | 3.78335954 |
20 | Aplastic anemia (HP:0001915) | 3.66531759 |
21 | Insomnia (HP:0100785) | 3.63478999 |
22 | Paralysis (HP:0003470) | 3.59114944 |
23 | Epistaxis (HP:0000421) | 3.58945755 |
24 | Polycythemia (HP:0001901) | 3.49988336 |
25 | Thrombocytosis (HP:0001894) | 3.47357497 |
26 | Macrocytic anemia (HP:0001972) | 3.46832488 |
27 | Abnormal gallbladder morphology (HP:0012437) | 3.35168008 |
28 | Purpura (HP:0000979) | 3.32724352 |
29 | Cutaneous photosensitivity (HP:0000992) | 3.17985871 |
30 | Osteomalacia (HP:0002749) | 3.02356381 |
31 | Abnormal platelet volume (HP:0011876) | 3.01471853 |
32 | Asplenia (HP:0001746) | 2.90248934 |
33 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.85601877 |
34 | Birth length less than 3rd percentile (HP:0003561) | 2.81172408 |
35 | Increased mean platelet volume (HP:0011877) | 2.75500147 |
36 | Menorrhagia (HP:0000132) | 2.74310702 |
37 | Hypertensive crisis (HP:0100735) | 2.63265551 |
38 | Increased serum ferritin (HP:0003281) | 2.61075388 |
39 | Myelodysplasia (HP:0002863) | 2.59118946 |
40 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.54445265 |
41 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 2.54026523 |
42 | Hyperthyroidism (HP:0000836) | 2.47452628 |
43 | IgM deficiency (HP:0002850) | 2.38475973 |
44 | Gingival bleeding (HP:0000225) | 2.37084480 |
45 | Abnormality of the gallbladder (HP:0005264) | 2.31562011 |
46 | Chronic otitis media (HP:0000389) | 2.31143628 |
47 | Short middle phalanx of the 5th finger (HP:0004220) | 2.30895474 |
48 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.30204578 |
49 | Abnormality of iron homeostasis (HP:0011031) | 2.28133041 |
50 | Autoimmune hemolytic anemia (HP:0001890) | 2.23867908 |
51 | Truncus arteriosus (HP:0001660) | 2.21050868 |
52 | Cholecystitis (HP:0001082) | 2.20433049 |
53 | Abnormal gallbladder physiology (HP:0012438) | 2.20433049 |
54 | Obstructive lung disease (HP:0006536) | 2.13370788 |
55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13370788 |
56 | Nausea (HP:0002018) | 2.12342616 |
57 | Depressed nasal tip (HP:0000437) | 2.11177069 |
58 | Cellulitis (HP:0100658) | 2.07494828 |
59 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.07096940 |
60 | Acute myeloid leukemia (HP:0004808) | 2.03290501 |
61 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 11.6019749 |
62 | Abnormality of the fingertips (HP:0001211) | 1.99941166 |
63 | Urticaria (HP:0001025) | 1.99895109 |
64 | Annular pancreas (HP:0001734) | 1.98501858 |
65 | Cerebral palsy (HP:0100021) | 1.97380852 |
66 | Osteomyelitis (HP:0002754) | 1.95821570 |
67 | Conjunctival telangiectasia (HP:0000524) | 1.94276496 |
68 | Hyperlipoproteinemia (HP:0010980) | 1.93763442 |
69 | Acute lymphatic leukemia (HP:0006721) | 1.93402436 |
70 | Toxemia of pregnancy (HP:0100603) | 1.92816162 |
71 | Spontaneous hematomas (HP:0007420) | 1.91950255 |
72 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91921819 |
73 | Broad palm (HP:0001169) | 1.90632527 |
74 | Prominent nose (HP:0000448) | 1.90230936 |
75 | Intestinal atresia (HP:0011100) | 1.89779279 |
76 | Anterior segment dysgenesis (HP:0007700) | 1.89632582 |
77 | Orthostatic hypotension (HP:0001278) | 1.89347004 |
78 | Albinism (HP:0001022) | 1.88205641 |
79 | Gastrointestinal infarctions (HP:0005244) | 1.87456819 |
80 | Thrombophlebitis (HP:0004418) | 1.85845983 |
81 | High pitched voice (HP:0001620) | 1.85444171 |
82 | Ventricular fibrillation (HP:0001663) | 1.84573671 |
83 | Amaurosis fugax (HP:0100576) | 1.83238345 |
84 | Abnormal large intestine physiology (HP:0012700) | 1.81840765 |
85 | Tinnitus (HP:0000360) | 1.80512600 |
86 | Seborrheic dermatitis (HP:0001051) | 1.79895668 |
87 | Recurrent viral infections (HP:0004429) | 1.79269292 |
88 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.78568785 |
89 | Pustule (HP:0200039) | 1.78101442 |
90 | Hypoparathyroidism (HP:0000829) | 1.77858007 |
91 | Encephalitis (HP:0002383) | 1.77389748 |
92 | Dyschromatopsia (HP:0007641) | 1.77006714 |
93 | Bowel incontinence (HP:0002607) | 1.76146408 |
94 | Thyroid carcinoma (HP:0002890) | 1.74654523 |
95 | Papillary thyroid carcinoma (HP:0002895) | 1.73827468 |
96 | Basal cell carcinoma (HP:0002671) | 1.73784298 |
97 | Migraine (HP:0002076) | 1.73721875 |
98 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.73429005 |
99 | Recurrent bacterial skin infections (HP:0005406) | 1.72573834 |
100 | Autoimmune thrombocytopenia (HP:0001973) | 1.71878523 |
101 | Volvulus (HP:0002580) | 1.70116878 |
102 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.68360290 |
103 | Inflammation of the large intestine (HP:0002037) | 1.67182935 |
104 | Hyponatremia (HP:0002902) | 1.66846233 |
105 | Bruising susceptibility (HP:0000978) | 1.66169249 |
106 | Abnormality of macrophages (HP:0004311) | 1.64910935 |
107 | Gastrointestinal dysmotility (HP:0002579) | 1.63970391 |
108 | Abnormality of homocysteine metabolism (HP:0010919) | 1.63956327 |
109 | Homocystinuria (HP:0002156) | 1.63956327 |
110 | Supernumerary spleens (HP:0009799) | 1.63794694 |
111 | Arterial thrombosis (HP:0004420) | 1.63640377 |
112 | Abnormality of the nasal mucosa (HP:0000433) | 1.60616507 |
113 | Hepatosplenomegaly (HP:0001433) | 1.60398536 |
114 | Abnormality of the prostate (HP:0008775) | 1.58395938 |
115 | Recurrent fungal infections (HP:0002841) | 1.57921631 |
116 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.56387780 |
117 | Hematochezia (HP:0002573) | 1.56233379 |
118 | Nonimmune hydrops fetalis (HP:0001790) | 1.55856243 |
119 | Recurrent abscess formation (HP:0002722) | 1.55713403 |
120 | Granulocytopenia (HP:0001913) | 1.55339110 |
121 | Poikiloderma (HP:0001029) | 1.54766136 |
122 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.54361373 |
123 | Fatigue (HP:0012378) | 1.53951152 |
124 | Cerebral hemorrhage (HP:0001342) | 1.51374028 |
125 | Leukocytosis (HP:0001974) | 1.50919189 |
126 | Abnormality of the duodenum (HP:0002246) | 1.50478134 |
127 | Abnormality of T cell physiology (HP:0011840) | 1.50341711 |
128 | Splenomegaly (HP:0001744) | 1.50116576 |
129 | Hyperacusis (HP:0010780) | 1.49946014 |
130 | Stomatitis (HP:0010280) | 1.48772624 |
131 | Hepatocellular carcinoma (HP:0001402) | 1.47514736 |
132 | Abnormality of the thoracic spine (HP:0100711) | 1.45954128 |
133 | Eczematoid dermatitis (HP:0000976) | 1.45786617 |
134 | Chromsome breakage (HP:0040012) | 1.44742498 |
135 | Erythema (HP:0010783) | 1.43984309 |
136 | Gastrointestinal inflammation (HP:0004386) | 1.43241040 |
137 | Panhypogammaglobulinemia (HP:0003139) | 1.42477029 |
138 | Ileus (HP:0002595) | 1.39438007 |
139 | Cutaneous melanoma (HP:0012056) | 1.39133952 |
140 | Squamous cell carcinoma (HP:0002860) | 1.38535572 |
141 | Small intestinal stenosis (HP:0012848) | 1.38224265 |
142 | Duodenal stenosis (HP:0100867) | 1.38224265 |
143 | Exertional dyspnea (HP:0002875) | 1.36466303 |
144 | Megalocornea (HP:0000485) | 1.36302907 |
145 | Bone marrow hypocellularity (HP:0005528) | 1.36023612 |
146 | Abnormality of chromosome stability (HP:0003220) | 1.35563725 |
147 | Increased nuchal translucency (HP:0010880) | 1.35550735 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.58077232 |
2 | EEF2K | 4.18877034 |
3 | EIF2AK1 | 3.87883673 |
4 | CDC7 | 3.17432444 |
5 | TIE1 | 3.06400063 |
6 | NME2 | 2.65492581 |
7 | BMX | 2.63536638 |
8 | TGFBR2 | 2.11865619 |
9 | TLK1 | 2.07726395 |
10 | MAP2K3 | 2.03157769 |
11 | PRPF4B | 2.00790075 |
12 | KIT | 1.97771988 |
13 | STK4 | 1.96003737 |
14 | KDR | 1.88028866 |
15 | VRK1 | 1.87877298 |
16 | TGFBR1 | 1.80341949 |
17 | WEE1 | 1.80174275 |
18 | RPS6KB2 | 1.78002306 |
19 | MAP4K1 | 1.76361299 |
20 | SCYL2 | 1.75080153 |
21 | MAP3K10 | 1.68363280 |
22 | BMPR2 | 1.61348544 |
23 | PIM1 | 1.61343487 |
24 | DYRK3 | 1.61091661 |
25 | PTK2B | 1.59368166 |
26 | TAOK2 | 1.51801672 |
27 | MAPKAPK5 | 1.47169663 |
28 | PKN2 | 1.47051991 |
29 | MST4 | 1.42347042 |
30 | TAOK3 | 1.40485126 |
31 | PIM2 | 1.40148209 |
32 | NEK2 | 1.38166223 |
33 | MKNK1 | 1.35487113 |
34 | CDK6 | 1.35396864 |
35 | CDK12 | 1.34848382 |
36 | BTK | 1.32181511 |
37 | SYK | 1.30751360 |
38 | STK10 | 1.27540617 |
39 | PIK3CG | 1.27119303 |
40 | MATK | 1.22469465 |
41 | CDK4 | 1.19134039 |
42 | PLK4 | 1.18733341 |
43 | HCK | 1.17341360 |
44 | ZAK | 1.11454791 |
45 | LRRK2 | 1.10695909 |
46 | BUB1 | 1.10556355 |
47 | MAPKAPK3 | 1.10505062 |
48 | RAF1 | 1.08905713 |
49 | STK3 | 1.08825418 |
50 | KSR2 | 1.07991423 |
51 | ATR | 1.06674294 |
52 | TEC | 1.05360104 |
53 | MARK3 | 1.05328853 |
54 | BRSK1 | 1.04227927 |
55 | AURKB | 1.03833626 |
56 | MUSK | 1.02734662 |
57 | ZAP70 | 1.02512528 |
58 | STK16 | 1.00389995 |
59 | RPS6KA5 | 0.98895685 |
60 | MAP3K1 | 0.98109130 |
61 | WNK1 | 0.97623583 |
62 | BRSK2 | 0.96648517 |
63 | JAK3 | 0.95939506 |
64 | NUAK1 | 0.95582678 |
65 | TNK2 | 0.95327362 |
66 | MAP3K8 | 0.95152054 |
67 | TAOK1 | 0.94662639 |
68 | MAP3K6 | 0.94597662 |
69 | BLK | 0.93873669 |
70 | IKBKB | 0.92690340 |
71 | ITK | 0.91553903 |
72 | TRPM7 | 0.89965794 |
73 | INSRR | 0.89637072 |
74 | MAP3K11 | 0.89600091 |
75 | BRD4 | 0.86964312 |
76 | CDK19 | 0.86533412 |
77 | CDK7 | 0.85739111 |
78 | FLT3 | 0.84613324 |
79 | GRK6 | 0.83492847 |
80 | MAPK11 | 0.82917883 |
81 | MAP3K2 | 0.82436566 |
82 | LYN | 0.82250886 |
83 | CDK8 | 0.81856319 |
84 | TBK1 | 0.80467582 |
85 | CDK9 | 0.78968004 |
86 | TYK2 | 0.77023040 |
87 | TRIB3 | 0.76745134 |
88 | MAP3K5 | 0.75894172 |
89 | JAK2 | 0.75632008 |
90 | AKT2 | 0.74712548 |
91 | MKNK2 | 0.70968560 |
92 | PASK | 0.70153701 |
93 | KSR1 | 0.69064803 |
94 | MAP3K3 | 0.68677749 |
95 | SIK2 | 0.67513501 |
96 | FGR | 0.66930646 |
97 | PRKAA2 | 0.65286643 |
98 | TXK | 0.63345200 |
99 | CAMK1G | 0.62399604 |
100 | GRK5 | 0.61827869 |
101 | IRAK1 | 0.61745989 |
102 | IKBKE | 0.61656776 |
103 | YES1 | 0.61435994 |
104 | SGK2 | 0.61176805 |
105 | SRPK1 | 0.60514650 |
106 | PAK4 | 0.60498055 |
107 | CSF1R | 0.60484179 |
108 | RPS6KA6 | 0.58836017 |
109 | PLK1 | 0.58470311 |
110 | CHEK1 | 0.58256968 |
111 | MAP2K2 | 0.58217101 |
112 | CHEK2 | 0.57957569 |
113 | ATM | 0.56596096 |
114 | PINK1 | 0.54663636 |
115 | RPS6KC1 | 0.54405558 |
116 | RPS6KL1 | 0.54405558 |
117 | SGK3 | 0.54005435 |
118 | TSSK6 | 0.53979821 |
119 | CLK1 | 0.53498508 |
120 | RPS6KA2 | 0.53153865 |
121 | HIPK2 | 0.52547123 |
122 | CAMK1D | 0.52500964 |
123 | MAPKAPK2 | 0.51661762 |
124 | ALK | 0.50947948 |
125 | RET | 0.50405009 |
126 | AURKA | 0.50135727 |
127 | PRKCQ | 0.49967231 |
128 | DYRK1B | 0.49930407 |
129 | PLK3 | 0.49533384 |
130 | CDK2 | 0.49006254 |
131 | CCNB1 | 0.48955624 |
132 | CSK | 0.47989161 |
133 | FES | 0.45342200 |
134 | MAPK12 | 0.45106344 |
135 | RPS6KA4 | 0.44467752 |
136 | TTK | 0.44134662 |
137 | ACVR1B | 0.43911112 |
138 | LCK | 0.43897450 |
139 | PDK1 | 0.42165207 |
140 | MAPK4 | 0.40604798 |
141 | PLK2 | 0.39984689 |
142 | IRAK4 | 0.36928396 |
143 | PDPK1 | 0.36139824 |
144 | SGK1 | 0.34907863 |
145 | * PRKACG | 0.30750235 |
146 | MAP3K7 | 0.30358277 |
147 | NTRK3 | 0.29922983 |
148 | IRAK3 | 0.28871109 |
149 | PAK1 | 0.26731886 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 5.06393145 |
2 | DNA replication_Homo sapiens_hsa03030 | 4.51924076 |
3 | Ribosome_Homo sapiens_hsa03010 | 4.42782176 |
4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.95790123 |
5 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 3.42943155 |
6 | Mismatch repair_Homo sapiens_hsa03430 | 2.90100879 |
7 | Base excision repair_Homo sapiens_hsa03410 | 2.49088418 |
8 | Cell cycle_Homo sapiens_hsa04110 | 2.42848147 |
9 | Spliceosome_Homo sapiens_hsa03040 | 2.36411255 |
10 | Homologous recombination_Homo sapiens_hsa03440 | 2.08145244 |
11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.03321053 |
12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.96940602 |
13 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.95171531 |
14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.91305350 |
15 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.90052452 |
16 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.88184843 |
17 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.82619647 |
18 | Alcoholism_Homo sapiens_hsa05034 | 1.73820722 |
19 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.70864882 |
20 | RNA transport_Homo sapiens_hsa03013 | 1.69300960 |
21 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.64495001 |
22 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.56520928 |
23 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.54302954 |
24 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.52813741 |
25 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.50915426 |
26 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.50078157 |
27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.45125075 |
28 | RNA degradation_Homo sapiens_hsa03018 | 1.39705165 |
29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.36013161 |
30 | Platelet activation_Homo sapiens_hsa04611 | 1.31803056 |
31 | RNA polymerase_Homo sapiens_hsa03020 | 1.30102572 |
32 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.29292937 |
33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.20538078 |
34 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.19370200 |
35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.19010290 |
36 | Apoptosis_Homo sapiens_hsa04210 | 1.18948194 |
37 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.18692366 |
38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.16227063 |
39 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.15160591 |
40 | Measles_Homo sapiens_hsa05162 | 1.14223946 |
41 | Olfactory transduction_Homo sapiens_hsa04740 | 1.10999133 |
42 | Hepatitis B_Homo sapiens_hsa05161 | 1.10719202 |
43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08710581 |
44 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.06752885 |
45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04534984 |
46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.03798260 |
47 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.03659533 |
48 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.03372287 |
49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.01510234 |
50 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.00655626 |
51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98301194 |
52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.97844142 |
53 | Malaria_Homo sapiens_hsa05144 | 0.97435073 |
54 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.97348317 |
55 | ABC transporters_Homo sapiens_hsa02010 | 0.97041926 |
56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96605078 |
57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95983864 |
58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.92776881 |
59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90512483 |
60 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.90196232 |
61 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88473033 |
62 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.87625720 |
63 | Tuberculosis_Homo sapiens_hsa05152 | 0.86939405 |
64 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86024410 |
65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81195755 |
66 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81139704 |
67 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80681015 |
68 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.80074524 |
69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.79975741 |
70 | Asthma_Homo sapiens_hsa05310 | 0.79585882 |
71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78867366 |
72 | Purine metabolism_Homo sapiens_hsa00230 | 0.78822407 |
73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77607804 |
74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.76241645 |
75 | Proteasome_Homo sapiens_hsa03050 | 0.75946462 |
76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75031847 |
77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71852548 |
78 | Glioma_Homo sapiens_hsa05214 | 0.71312210 |
79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69277957 |
80 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.68852823 |
81 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.66523883 |
82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66459483 |
83 | Long-term depression_Homo sapiens_hsa04730 | 0.65505910 |
84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64573437 |
85 | Influenza A_Homo sapiens_hsa05164 | 0.64375334 |
86 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.62939680 |
87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62267935 |
88 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.62047950 |
89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61018669 |
90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.60993030 |
91 | Basal transcription factors_Homo sapiens_hsa03022 | 0.60194932 |
92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.59614253 |
93 | Bladder cancer_Homo sapiens_hsa05219 | 0.58487527 |
94 | Legionellosis_Homo sapiens_hsa05134 | 0.56259552 |
95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52442785 |
96 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51956493 |
97 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51248130 |
98 | Shigellosis_Homo sapiens_hsa05131 | 0.50202727 |
99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48714550 |
100 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.48595845 |
101 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48091127 |
102 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.46736409 |
103 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46362470 |
104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44976264 |
105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44673507 |
106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43990872 |
107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43669260 |
108 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.42456275 |
109 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.42191037 |
110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41747629 |
111 | Gap junction_Homo sapiens_hsa04540 | 0.40790219 |
112 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.39605539 |
113 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.38952051 |
114 | Prostate cancer_Homo sapiens_hsa05215 | 0.38949558 |
115 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.38695878 |
116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38366549 |
117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38298517 |
118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37731216 |
119 | Endocytosis_Homo sapiens_hsa04144 | 0.37381932 |
120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37020850 |
121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36556986 |
122 | Melanoma_Homo sapiens_hsa05218 | 0.36059148 |
123 | Pertussis_Homo sapiens_hsa05133 | 0.35834343 |
124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34966851 |
125 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.34662926 |
126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34258167 |
127 | Lysine degradation_Homo sapiens_hsa00310 | 0.34003710 |
128 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.33980973 |
129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33829520 |
130 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33760263 |
131 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.33401271 |
132 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.33353748 |
133 | Hepatitis C_Homo sapiens_hsa05160 | 0.32877764 |
134 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.32708699 |
135 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32064930 |
136 | Phagosome_Homo sapiens_hsa04145 | 0.31977309 |
137 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.27270471 |
138 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26353287 |
139 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.26049582 |
140 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.25899050 |
141 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.25678717 |
142 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21389683 |